当前位置:循环首页>正文

[AHA2010]AHA主席畅谈大会亮点和卒中预防——Ralph L Sacco教授专访

作者:  RalphLSacco   日期:2010/11/17 15:18:01

国际循环网版权所有,谢绝任何形式转载,侵犯版权者必予法律追究。

<International Circulation >: Doctor, at AHA 2010 there are many interest sessions here at this scientific sessions, can you highlight what you have found to be most interesting?

  <International Circulation >:What is the latest anti-thrombotic therapy for stroke?

 《国际循环》:最新的抗血栓中风治疗有哪些?

  Dr Sacco: For stroke, like other cardiovascular diseases, the one main drug we use is aspirin for preventing a recurrent stroke because most studies have shown that aspirin is effective in terms of reducing the risk of recurrent stroke.  The other anti platelet agents that are being used include extended release Dipyridamole and aspirin and Clopidogrel.  These agents have been shown to be more effective than aspirin in terms of reducing the risk of a recurring stroke.  Other agents for patients who have cardioembolic stroke – that is strokes from abnormal heart rhythm like atrial fibrillation -- warfarin is usually the best therapy.  Most recently approved in the United States is a direct thrombin inhibitor called Dabigatran that will soon be available for patients with atrial fibrillation.

 Sacco博士:像其他心血管疾病一样,仍然应用的一大药物是阿司匹林以预防中风复发。大多数研究证明阿司匹林在降低中风复发的风险方面有效。其他用于抗血小板的药物包括缓释双嘧达莫、阿司匹林和氯吡格雷。这些药物在降低中风复发的风险方面与阿司匹林一样有效。有治疗心脏相关性中风的其他药物 - 心律异常如房颤导致的中风,华法林通常是最好的治疗,最近在美国批准了一种直接凝血酶抑制剂药物达比加群,很快上市,适用于心颤病人。

上一页  [1]  [2]  [3]  [4]  [5]  下一页

版面编辑:沈会会  责任编辑:张衡



卒中预防房颤阿司匹林R. L.Sacco教授

分享到: 更多


设为首页 | 加入收藏 | 关于我们 | 联系方式 | 招贤纳士
声明:国际循环网( www.icirculation.com)对刊载的所有文章、视频、幻灯、音频等资源拥有全部版权。未经本站许可,不得转载。
京ICP备15014970号-5  互联网药品信息服务资格证书编号(京)-非经营性-2017-0063  京公网安备 11010502033353号  增值电信业务经营许可证:京ICP证150541号
国际循环 版权所有   © 2004-2024 www.icirculation.com All Rights Reserved
公司名称:北京美赞广告有限公司 公司地址:北京市朝阳区朝阳门北大街乙12号天辰大厦1座1409 电话:010-51295530